drugset / Trial / NCT07337512

Moringa Oleifera and Phoenix Dactylifera L. Effects on Cortisol and Breast Milk in Postpartum Depression

NCT07337512

Completed 363 enrolled Melania Asi Indonesia-MoH · collab
NaSingle-groupOpen-labelTreatment

Summary

Postpartum depression affects 10-20% of new mothers globally, potentially disrupting breast milk production. This study aimed to provide valuable insights into effective interventions to improve the health and well-being of Postpartum Mothers with depression. This study used a randomized controlled trial design with three groups: intervention 1 (dates), intervention 2 (Moringa oleifera), and a control group. A total of 363 postpartum mothers participated, and data were collected through salivary cortisol levels (ELISA) and Beck Depression Inventory (BDI) scores to measure depression levels and breast milk production (ACIS AC-15X digital scale and Crown electric breast pump) before and after the intervention for 28 days. Data analysis was performed using paired sample t-test and the independent t-test.

Timeline

Start
2024-05-19
Primary completion
2024-11-19
Completion
2024-11-19

Drugs

EvaluationDrugModalityDoseRoute
Comparator Moringa Oleifera Unknown 1000 mg
Comparator Phoenix dactylifera L Unknown 120 g

Indications